A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)

Clinical trial NCT06287528 · RECRUITING

Trial details

NCT number: NCT06287528
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Philadelphia-Negative ALL Philadelphia-Positive ALL Relapsed ALL, Adult Refractory Acute Lymphoblastic Leukemia Refractory Acute Lymphoblastic Leukemia (ALL)Refractory Acute Lymphoid Leukemia in Relapse

Start date: 2024-02-23
Primary completion: 2028-02-23
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.